Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM ACETATE.
POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium chloride dissociates to provide potassium ions, which are essential for maintaining intracellular osmolarity, acid-base balance, and normal nerve conduction and muscle contraction, including cardiac muscle. Dextrose provides a source of calories and may prevent ketosis.
Sodium acetate provides sodium ions and acetate ions. Acetate is metabolized to bicarbonate, which acts as a buffer to correct metabolic acidosis.
Intravenous infusion of potassium chloride 0.037% in dextrose 5% at a rate not exceeding 10 mEq/hour of potassium and a maximum concentration of 40 mEq/L in peripheral veins; dose determined by serum potassium level and clinical need, typically 20-40 mEq per day for mild depletion.
Intravenous: 50-200 mL of 0.1-0.4 mEq/mL solution per dose; administer at a rate not exceeding 1 mEq/kg/hour; frequency based on serum bicarbonate and acid-base status.
None Documented
None Documented
Potassium has a complex disposition; the distribution between intracellular and extracellular compartments affects half-life. In normal renal function, the serum potassium half-life is approximately 4-6 hours after a dose, but this is not a true terminal half-life due to extensive tissue buffering. The body's total potassium turnover half-life is around 25-30 hours. In patients with renal impairment, half-life is prolonged proportionally to creatinine clearance.
2-3 minutes (rapid conversion to bicarbonate in circulation). Clinical context: Exogenous acetate (e.g., in parenteral nutrition) is quickly cleared, limiting duration of alkalinizing effect.
Potassium is primarily excreted renally (>90%) with about 10% excreted in feces via gastrointestinal secretion. Minimal excretion occurs through sweat. Renal handling involves glomerular filtration, proximal tubular reabsorption, and potassium secretion in the distal tubule and collecting duct regulated by aldosterone. Excretion is not linear and depends on potassium balance, renal function, and hormonal influences.
Primarily renal; acetate is rapidly metabolized to bicarbonate via the Krebs cycle, with less than 5% excreted unchanged in urine.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement